164 related articles for article (PubMed ID: 27787359)
21. Promoter methylation and down-regulation of DAPK is associated with gastric atrophy.
Kim WS; Son HJ; Park JO; Song SY; Park C
Int J Mol Med; 2003 Dec; 12(6):827-30. PubMed ID: 14612952
[TBL] [Abstract][Full Text] [Related]
22. [Expression of death-associated protein kinase gene and methylation status of promoter region in acute leukemia].
Niu YM; Wang PP; Wang Y; Wang YZ; Cai DL; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):30-4. PubMed ID: 24598646
[TBL] [Abstract][Full Text] [Related]
23. Role of p16 gene promoter methylation in gastric carcinogenesis: a meta-analysis.
Wang HL; Zhou PY; Liu P; Zhang Y
Mol Biol Rep; 2014 Jul; 41(7):4481-92. PubMed ID: 24610350
[TBL] [Abstract][Full Text] [Related]
24. Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer.
Sugita H; Iida S; Inokuchi M; Kato K; Ishiguro M; Ishikawa T; Takagi Y; Enjoji M; Yamada H; Uetake H; Kojima K; Sugihara K
Oncol Rep; 2011 Feb; 25(2):513-8. PubMed ID: 21152877
[TBL] [Abstract][Full Text] [Related]
25. Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma.
Liu XF; Kong FM; Xu Z; Yu SP; Sun FB; Zhang CS; Huang QX; Zhou XT; Song ZW
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):407-11. PubMed ID: 17690039
[TBL] [Abstract][Full Text] [Related]
26. Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome.
Hoffmann AC; Vallböhmer D; Prenzel K; Metzger R; Heitmann M; Neiss S; Ling F; Hölscher AH; Schneider PM; Brabender J
J Cancer Res Clin Oncol; 2009 Sep; 135(9):1231-7. PubMed ID: 19259700
[TBL] [Abstract][Full Text] [Related]
27. Methylation of the APAF-1 and DAPK-1 promoter region correlates with progression of renal cell carcinoma in North Indian population.
Ahmad ST; Arjumand W; Seth A; Saini AK; Sultana S
Tumour Biol; 2012 Apr; 33(2):395-402. PubMed ID: 21922274
[TBL] [Abstract][Full Text] [Related]
28. [Promoter methylation and expression of death-associated protein kinase gene in acute leukemia].
Zhao WH; Meng FY; Lai YR; Peng ZG; Ma J
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Mar; 37(3):407-410. PubMed ID: 28377362
[TBL] [Abstract][Full Text] [Related]
29. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
[TBL] [Abstract][Full Text] [Related]
30. 5-Aza-CdR can reverse gefitinib resistance caused by DAPK gene promoter methylation in lung adenocarcinoma cells.
Yang B; Yang ZG; Gao B; Shao GG; Li GH
Int J Clin Exp Pathol; 2015; 8(10):12961-6. PubMed ID: 26722491
[TBL] [Abstract][Full Text] [Related]
31. Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett's esophageal adenocarcinoma and its association with clinical progression.
Kuester D; Dar AA; Moskaluk CC; Krueger S; Meyer F; Hartig R; Stolte M; Malfertheiner P; Lippert H; Roessner A; El-Rifai W; Schneider-Stock R
Neoplasia; 2007 Mar; 9(3):236-45. PubMed ID: 17401463
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic down-regulation of death-associated protein kinase in lung cancers.
Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF
Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953
[TBL] [Abstract][Full Text] [Related]
33. [Alteration of methylation status of death-associated protein kinase (dapk) gene promoter in patients with acute myeloid leukemia].
Qian J; Yao DM; Lin J; Chen Q; Li Y; Ji RB; Yang J; Qian Z; Xiao GF; Wang YL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1390-4. PubMed ID: 21176336
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
35. A gene expression profile of tumor suppressor genes commonly methylated in bladder cancer.
Christoph F; Hinz S; Kempkensteffen C; Weikert S; Krause H; Schostak M; Schrader M; Miller K
J Cancer Res Clin Oncol; 2007 Jun; 133(6):343-9. PubMed ID: 17160380
[TBL] [Abstract][Full Text] [Related]
36. Promoter hypermethylation patterns of P16, DAPK and MGMT in oral squamous cell carcinoma: a systematic review and meta-analysis.
Don KR; Ramani P; Ramshankar V; Sherlin HJ; Premkumar P; Natesan A
Indian J Dent Res; 2014; 25(6):797-805. PubMed ID: 25728117
[TBL] [Abstract][Full Text] [Related]
37. Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression.
Iliopoulos D; Oikonomou P; Messinis I; Tsezou A
Oncol Rep; 2009 Jul; 22(1):199-204. PubMed ID: 19513524
[TBL] [Abstract][Full Text] [Related]
38. Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics.
Jeong DH; Youm MY; Kim YN; Lee KB; Sung MS; Yoon HK; Kim KT
Int J Gynecol Cancer; 2006; 16(3):1234-40. PubMed ID: 16803511
[TBL] [Abstract][Full Text] [Related]
39. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.
Schildhaus HU; Kröckel I; Lippert H; Malfertheiner P; Roessner A; Schneider-Stock R
Int J Oncol; 2005 Jun; 26(6):1493-500. PubMed ID: 15870861
[TBL] [Abstract][Full Text] [Related]
40. [Reversion transcriptional expression of DAPK in bladder cancer T24 cells 5-aza-2'-deoxycytidine].
Xu NR; Liu CX; Zheng SB; Li HL; Xu YW; Xu K
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep; 29(9):1882-6. PubMed ID: 19778817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
